Breast Cancer rates soar for post menopausal women taking statin drugs

Breast Cancer Risk Increases by 85-97 percent in Women, 55-74 years old,  Who Use Statin Drugs for 10 years

No wonder breast cancer rates for  postmenopausal women are possibly  the highest/the most horrible in the world; with the National Cancer Institute’s Philip  Rosenberg recently predicting that current breast cancer rates in post-menopausal  women will increase 50 percent  by 2030 as  baby boomer women grow older.  The culprit, it turns out, is not so much age… as the drugs these women have been  asked to take.

We already know about those progestin based HRT drugs... they raise breast cancer incidence by 26 percent in  post menopausal women  who use Prempro and other “combo” HRT drugs.

Next we learn that  breast cancer risk increases by 91 percent in this same age group, among those who have taken  statin drugs for more than ten years. We are talking about  drugs with names such as: Zocor, Mevacor, Cresto, Pravachol and Vytorin. 

Aside from being a huge money- making product  for pharmaceutical companies,  statins are now causing lots of unnecessary breast cancer diagnoses.  According to a study from nationally respected epidemiologists at the Fred Hutchinson Cancer Research Center in Seattle,  older women who take these drugs for more than 10 years have an 83% increase in invasive ductal carcinoma and a 97%increase in invasive lobular carcinoma.

And to make this whole troubling statin scenario even more worrisome, we are also learning that statin drugs do not even lower  a person’s heart attack risk; their alleged   goal in the first place.

Just as few physicians are aware of this 2013 statin and breast cancer study, the medical profession also seems unaware of the fact that most individuals’ blood cholesterol readings have little to do with the amount of  good or bad fats a person eats every day.

Best selling authors, Drs David Brownstein and David Perlmutter,  have both uncovered many of these  anti-statin research studies that have long been ignored or left unfunded by our federal health agencies.

Meanwhile, Dr David Diamond, a professor at the University of South Florida, has discovered that drug company-sponsored or influenced studies on statin drugs over past years, have twisted statistics to make these drugs look like the good guys, when they are not.

See  Brownstein’s excellent post on this subject

Read Dr Perlmutter’s assessment of statins.

Listen to  Dr. Diamond’s expose of the false numbers used in many published statin studies.

Also see the : The Hutchinson Study:   Long-term statin use and risk of ductal and lobular breast cancer among women 55-74 years of age.